Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort
Sign Up to like & getrecommendations! Published in 2020 at "Neurology"
DOI: 10.1212/wnl.0000000000009155
Abstract: Objective To assess the frequency and utilization trends of dabigatran reversal with idarucizumab and compare associated complications, outcomes, and door-to-needle times to those of patients not exposed to idarucizumab in a nationwide cohort of thrombolyzed… read more here.
Keywords: dabigatran reversal; reversal idarucizumab; idarucizumab; thrombolyzed patients ... See more keywords
Stroke Reperfusion Therapy Following Dabigatran Reversal With Idarucizumab in a National Cohort
Sign Up to like & getrecommendations! Published in 2021 at "Neurology"
DOI: 10.1212/wnl.0000000000009542
Abstract: In the article “Stroke Reperfusion Therapy Following Dabigatran Reversal With Idarucizumab in a National Cohort” by Barber et al.,1 the first sentence in the Methods section should denote this study as providing Class III evidence.… read more here.
Keywords: therapy following; dabigatran reversal; reperfusion therapy; reversal idarucizumab ... See more keywords
TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11051480
Abstract: Reperfusion therapy for acute ischemic stroke aims to restore the blood flow of occluded blood vessels. However, successful recanalization is often associated with disruption of the blood-brain barrier, leading to reperfusion injury. Delayed recanalization increases… read more here.
Keywords: stroke reperfusion; blocking antibody; reperfusion; trpm4 blocking ... See more keywords